Trial
NCT06190912
Safety of Bryostatin in Patients With MS
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Robert Fox
Collaborators
Synaptogenix, Inc.
Condition
Multiple Sclerosis
Intervention
Bryostatin 1
Why stopped
Sponsor terminated funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-31